|
1
|
Caporali A, Meloni M, Nailor A, Mitić T,
Shantikumar S, Riu F, Sala-Newby GB, Rose L, Besnier M, Katare R,
et al: p75(NTR)-dependent activation of NF-κB regulates
microRNA-503 transcription and pericyte-endothelial crosstalk in
diabetes after limb ischaemia. Nat Commun. 6:80242015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lunder M, Janić M and Šabovič M:
Prevention of vascular complications in diabetes mellitus patients:
Focus on the arterial wall. Curr Vasc Pharmacol. 17:6–15. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barshes NR and Grant CL: Advances in the
management of peripheral artery disease. Curr Diab Rep. 19:362019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dal Canto E, Ceriello A, Rydén L, Ferrini
M, Hansen TB, Schnell O, Standl E and Beulens JW: Diabetes as a
cardiovascular risk factor: An overview of global trends of macro
and micro vascular complications. Eur J Prev Cardiol. 26
(2_suppl):25–32. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He S, Zhao T, Guo H, Meng Y, Qin G,
Goukassian DA, Han J, Gao X and Zhu Y: Coordinated activation of
VEGF/VEGFR-2 and PPARδ pathways by a multi-component Chinese
medicine DHI accelerated recovery from peripheral arterial disease
in type 2 diabetic mice. PLoS One. 11:e01673052016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nazer B, Ghahghaie F, Kashima R, Khokhlova
T, Perez C, Crum L, Matula T and Hata A: Therapeutic ultrasound
promotes reperfusion and angiogenesis in a rat model of peripheral
arterial disease. Circ J. 79:2043–2049. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhu Y, Wang Y, Jia Y, Xu J and Chai Y:
Roxadustat promotes angiogenesis through HIF-1α/VEGF/VEGFR2
signaling and accelerates cutaneous wound healing in diabetic rats.
Wound Repair Regen. 27:324–334. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lazarovici P, Lahiani A, Gincberg G, Haham
D, Fluksman A, Benny O, Marcinkiewicz C and Lelkes PI: Nerve growth
factor-induced angiogenesis: 1. Endothelial cell tube formation
assay. Methods Mol Biol. 1727:239–250. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Can L, Junxiong Z, Bao H, Wen Z, Hong W,
Huijie L, Yingsheng X and Chunli S: Single intraosseous injection
of simvastatin promotes endothelial progenitor cell mobilization,
neovascularization, and wound healing in diabetic rats. Plast
Reconstr Surg. 145:433–443. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Odent Grigorescu G, Rosca AM, Preda MB,
Tutuianu R, Simionescu M and Burlacu A: Synergic effects of VEGF-A
and SDF-1 on the angiogenic properties of endothelial progenitor
cells. J Tissue Eng Regen Med. 11:3241–3252. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tiwari A, Mukherjee B and Dixit M:
MicroRNA key to angiogenesis regulation: MiRNA biology and therapy.
Curr Cancer Drug Targets. 18:266–277. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gong M, Yu B, Wang J, Wang Y, Liu M, Paul
C, Millard RW, Xiao DS, Ashraf M and Xu M: Mesenchymal stem cells
release exosomes that transfer miRNAs to endothelial cells and
promote angiogenesis. Oncotarget. 8:45200–45212. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Y, Yang Q, Zhan Y, Ke J, Lv P and
Huang J: The role of miR-328 in high glucose-induced
endothelial-to-mesenchymal transition in human umbilical vein
endothelial cells. Life Sci. 207:110–116. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li DS, Feng L, Luo LH, Duan ZF, Li XL, Yin
CH and Sun X: The Effect of microRNA-328 antagomir on erectile
dysfunction in streptozotocin-induced diabetic rats. Biomed
Pharmacother. 92:888–895. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yi W, Tu MJ, Liu Z, Zhang C, Batra N, Yu
AX and Yu AM: Bioengineered miR-328-3p modulates GLUT1-mediated
glucose uptake and metabolism to exert synergistic
antiproliferative effects with chemotherapeutics. Acta Pharm Sin B.
10:159–170. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Prado MSG, de Goes TC, de Jesus ML,
Mendonça LSO, Nascimento JS and Kaneto CM: Identification of
miR-328-3p as an endogenous reference gene for the normalization of
miRNA expression data from patients with Diabetic Retinopathy. Sci
Rep. 9:196772019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Caporali A, Meloni M, Völlenkle C, Bonci
D, Sala-Newby GB, Addis R, Spinetti G, Losa S, Masson R, Baker AH,
et al: Deregulation of microRNA-503 contributes to diabetes
mellitus-induced impairment of endothelial function and reparative
angiogenesis after limb ischemia. Circulation. 123:282–291. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ying C, Sui-Xin L, Kang-Ling X, Wen-Liang
Z, Lei D, Yuan L, Fan Z and Chen Z: MicroRNA-492 reverses high
glucose-induced insulin resistance in HUVEC cells through targeting
resistin. Mol Cell Biochem. 391:117–125. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang M, Li W, Chang GQ, Ye CS, Ou JS, Li
XX, Liu Y, Cheang TY, Huang XL and Wang SM: MicroRNA-21 regulates
vascular smooth muscle cell function via targeting tropomyosin 1 in
arteriosclerosis obliterans of lower extremities. Arterioscler
Thromb Vasc Biol. 31:2044–2053. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−ΔΔC(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen M, Yi B, Zhu N, Wei X, Zhang GX,
Huang S and Sun J: Pim1 kinase promotes angiogenesis through
phosphorylation of endothelial nitric oxide synthase at Ser-633.
Cardiovasc Res. 109:141–150. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Durak-Kozica M, Paszek E and Stępień EŁ:
Role of the Wnt signalling pathway in the development of
endothelial disorders in response to hyperglycaemia. Expert Rev Mol
Med. 21:e72019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schiano C, Grimaldi V, Franzese M, Fiorito
C, De Nigris F, Donatelli F, Soricelli A, Salvatore M and Napoli C:
Non-nutritional sweeteners effects on endothelial vascular
function. Toxicol In Vitro. 62:1046942020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang J, Yang L, Liang F, Chen Y and Yang
G: Integrin alpha × stimulates cancer angiogenesis through PI3K/Akt
signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel
endothelial cells. J Cell Biochem. 120:1807–1818. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qian Z, Zhang L, Chen J, Li Y, Kang K, Qu
J, Wang Z, Zhai Y, Li L and Gou D: MiR-328 targeting PIM-1 inhibits
proliferation and migration of pulmonary arterial smooth muscle
cells in PDGFBB signaling pathway. Oncotarget. 7:54998–55011. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Han N, Zhao W, Zhang Z and Zheng P:
MiR-328 suppresses the survival of esophageal cancer cells by
targeting PLCE1. Biochem Biophys Res Commun. 470:175–180. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang X, Xin G and Sun D: Serum exosomal
miR-328, miR-575, miR-134 and miR-671-5p as potential biomarkers
for the diagnosis of Kawasaki disease and the prediction of
therapeutic outcomes of intravenous immunoglobulin therapy. Exp
Ther Med. 16:2420–2432. 2018.PubMed/NCBI
|
|
28
|
Li Y, Duo Y, Zhai P, He L, Zhong K, Zhang
Y, Huang K, Luo J, Zhang H and Yu X: Dual targeting delivery of
miR-328 by functionalized mesoporous silica nanoparticles for
colorectal cancer therapy. Nanomedicine (Lond). 13:1743–5889. 2018.
View Article : Google Scholar
|
|
29
|
Zhao D, Li C, Yan H, Li T, Qian M, Zheng
N, Jiang H, Liu L, Xu B, Wu Q, et al: Cardiomyocyte derived mir-328
promotes cardiac fibrosis by paracrinely regulating adjacent
fibroblasts. Cell Physiol Biochem. 46:1555–1565. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Soeki T, Matsuura T, Bando S, Tobiume T,
Uematsu E, Ise T, Kusunose K, Yamaguchi K, Yagi S, Fukuda D, et al:
Relationship between local production of microRNA-328 and atrial
substrate remodeling in atrial fibrillation. J Cardiol. 68:472–477.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He F, Lv P, Zhao X, Wang X, Ma X, Meng W,
Meng X and Dong S: Predictive value of circulating miR-328 and
miR-134 for acute myocardial infarction. Mol Cell Biochem.
394:137–144. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yan X, Hui Y, Hua Y, Huang L, Wang L, Peng
F, Tang C, Liu D, Song J and Wang F: EG-VEGF silencing inhibits
cell proliferation and promotes cell apoptosis in pancreatic
carcinoma via PI3K/AKT/mTOR signaling pathway. Biomed Pharmacother.
109:762–769. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Di Y and Chen XL: Inhibition of LY294002
in retinal neovascularization via down-regulation the PI3K/AKT-VEGF
pathway in vivo and in vitro. Int J Ophthalmol. 11:1284–1289.
2018.PubMed/NCBI
|
|
34
|
Chen J, Li F, Xu Y, Zhang W, Hu Y, Fu Y,
Xu W, Ge S, Fan X and Lu L: Cholesterol modification of
SDF-1-specific siRNA enables therapeutic targeting of angiogenesis
through Akt pathway inhibition. Exp Eye Res. 184:64–71. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu J, Zhao X, Sun Q, Jiang Y, Zhang W, Luo
J and Li Y: Synergic effect of PD-1 blockade and endostar on the
PI3K/AKT/mTOR-mediated autophagy and angiogenesis in Lewis lung
carcinoma mouse model. Biomed Pharmacother. 125:1097462020.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hu XF, Li J, Vandervalk S, Wang Z,
Magnuson NS and Xing PX: PIM-1-specific mAb suppresses human and
mouse tumor growth by decreasing PIM-1 levels, reducing Akt
phosphorylation, and activating apoptosis. J Clin Invest.
119:362–375. 2009.PubMed/NCBI
|
|
37
|
Fathi AT, Arowojolu O, Swinnen I, Sato T,
Rajkhowa T, Small D, Marmsater F, Robinson JE, Gross SD, Martinson
M, et al: A potential therapeutic target for FLT3-ITD AML: PIM1
kinase. Leuk Res. 36:224–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen QY, Jiao DM, Wu YQ, Chen J, Wang J,
Tang XL, Mou H, Hu HZ, Song J, Yan J, et al: MiR-206 inhibits
HGF-induced epithelial-mesenchymal transition and angiogenesis in
non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Oncotarget. 7:18247–18261. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang Y, Cheng H, Li W, Wu H and Yang Y:
Highly-expressed P2X7 receptor promotes growth and metastasis of
human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and
mTOR/HIF1α/VEGF signaling. Int J Cancer. 145:1068–1082. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Baigude H and Rana TM: Strategies to
antagonize miRNA functions in vitro and in vivo. Nanomediwcine
(Lond). 9:2545–2555. 2014. View Article : Google Scholar
|
|
41
|
Zhang F, Beharry ZM, Harris TE, Lilly MB,
Smith CD, Mahajan S and Kraft AS: PIM1 protein kinase regulates
PRAS40 phosphorylation and mTOR activity in FDCP1 cells. Cancer
Biol Ther. 8:846–853. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Leung CO, Wong CC, Fan DN, Kai AK, Tung
EK, Xu IM, Ng IO and Lo RC: PIM1 regulates glycolysis and promotes
tumor progression in hepatocellular carcinoma. Oncotarget.
6:10880–10892. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Walpen T, Kalus I, Schwaller J, Peier MA,
Battegay EJ and Humar R: Nuclear PIM1 confers resistance to
rapamycin-impaired endothelial proliferation. Biochem Biophys Res
Commun. 429:24–30. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Walpen T, Peier M, Haas E, Kalus I,
Schwaller J, Battegay E and Humar R: Loss of pim1 imposes a
hyperadhesive phenotype on endothelial cells. Cell Physiol Biochem.
30:1083–1096. 2012. View Article : Google Scholar : PubMed/NCBI
|
